Table 1 Baseline demographic and clinical characteristics
From: Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease
Characteristics | N = 305 |
|---|---|
Age (years) | 63.7 ± 10.0 |
Male sex | 187 (61.3%) |
Creatinine (mg/dL) | 1.07 (0.34, 10.15) |
hs-TnT (ng/l) | 13.20 (3.09, 294.20) |
hs-CRP (mg/l) | 1.47 (0.15, 130.05) |
Kynurenine (µM) | 4.94 (0.00, 11,731.00) |
Tryptophan (µM) | 36.99 (0.00, 43,111.29) |
IDO activity | 0.14 (0.00, 4.58) |
Diabetes | 134 (43.9%) |
Hypertension | 272 (89.2%) |
Dyslipidemia | 233 (76.4%) |
Recent ACS | |
STEMI | 31 (10.2%) |
Non STEMI | 53 (17.4%) |
Unstable angina | 14 (4.6%) |
Stable CAD | 114 (37.4%) |
Other (Pre-op valvular HD / HF / Reduced EF) | 93 (30.5%) |
Ischemic stroke | 13 (4.3%) |
Peripheral vascular disease | 14 (4.6%) |
Current medications | |
ASA | 269 (88.2%) |
Plavix | 183 (60.0%) |
Beta blockers | 245 (80.3%) |
Statin | 258 (84.6%) |
Baseline coronary angiography | |
Nonsignificant CAD | 78 (25.6%) |
Single-vessel disease | 81 (26.6%) |
Double-vessel disease | 66 (21.6%) |
Triple-vessel disease | 80 (26.2%) |
Treatment following baseline coronary angiography | |
Medication only | 123 (40.3%) |
PCI | 145 (47.5%) |
CABG | 37 (12.1%) |